Momentum
Relative Strength (%)
1m +2.4%
3m -1.7%
1yr -12.8%
Volume Change (%)
10d v 3m -15.1%
Price vs... (%)
52w High -12.0%
50d MA +5.92%
200d MA +0.43%
vs.
market
vs.
industry
Growth & Value
Trailing 12m
PE Ratio (ttm) n/a
PEG Ratio (ttm) n/a
EPS Growth (ttm) n/a %
Dividend Yield (ttm) 3.03 %
Valuation (ttm)
Price to Book Value 0.83
Price to Tang. Book 0.83
Price to Free Cashflow n/a
Price to Sales -10.1
EV to EBITDA n/a

Margin of Safety (beta)
Screens Passed

MNL doesn't qualify for our screens.
Find out why:   View Checklists

vs.
market
vs.
industry
Quality
Return on Capital -9.78 %
Return on Equity -9.03 %
Operating Margin 120 %
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Jul 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue £m 1.46 13.5 16.3 -18.9 3.58 -5.24
Operating Profit £m 0.67 13.2 15.7 -19.9 2.52 -6.30
Net Profit £m 0.65 13.2 15.7 -19.9 2.52 -6.30
EPS Reported p 4.43 71.8 69.9 -88.8 11.2 -28.1
EPS Normalised p 4.43 71.8 69.9 -88.8 11.2 -28.1
EPS Growth % +1,520 -2.6
PE Ratio x n/a n/a n/a
PEG x n/a n/a n/a
Profitability
Operating Margin % 45.2 97.5 96.0 105.7 70.5 120 +89.2%
ROA % 17.2 14.1 -17.7 2.6
ROCE % 1.1 15.4 16.0 -26.4 3.4 -9.8 -0.05%
ROE % 18.4 17.1 -23.0 3.4 -9.0 +1.4%
Cashflow
Op. Cashflow ps p 4.55 3.52 3.02 13.5 -3.41 -63.9
Capex ps p 0.000 0.000 0.000 0.000 0.000 0.000
Free Cashflow ps p 4.55 3.52 3.02 13.5 -3.41 -63.9
Last ex-div: 20th Nov, paid: 28th Nov more... Dividends
Dividend ps p 10.5 11.5 12.5 13.0 13.8 7.48 -6.6%
Dividend Growth % +5.00 +9.52 +8.70 +4.00 +5.77 -45.6
Dividend Yield % 3.03
Dividend Cover x 0.43 6.24 5.59 -6.83 0.82 -3.75
Balance Sheet
Cash etc £m 4.75 2.03 7.69 11.4 21.8 19.6 +32.8%
Working Capital £m 5.57 0.86 -26.0 -4.45 -0.64 18.7 +27.4%
Net Fixed Assets £m 51.9 84.3 124.3 80.0 75.7 45.7 -2.5%
Net Debt £m -0.88 2.14 26.0 -1.53 -10.8 -19.6
Book Value £m 57.5 85.2 98.3 75.5 75.1 64.4 +2.3%
Average Shares m 14.6 18.3 22.5 22.5 22.5 22.4 +9.0%
Book Value ps p 328.5 379.4 437.6 336.3 334.2 293.2 -2.2%

FINANCIAL BRIEF: For the fiscal year ended 31 July 2014, Manchester & London Investment Trust plc revenues decreased from L3.6M to -L5.2M. Net loss totaled L6.3M vs. income of L2.5M. Revenues reflect through profit or loss decrease from -L240K to -L9.1M. Net loss reflects Cost of Investment Transactions increase from L82K to L170K (expense), Exchange rate variances increase from L3K to L45K (expense), Registrar fees increase of 10% to L11K (expense). more »

Health Trend

Bankruptcy Risk

N/A Earnings Manipulation Risk

Magic Formula Score

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing % 0.000 0.000
Net Gearing % -30.5 -30.5
Cash / Assets % 29.9
Liquidity (ttm)
Curr. Ratio 15.2
Quick Ratio 15.2
Interest Cov. n/a
Efficiency (ttm)
Asset Turnover -0.052
Rec's Turnover -95.3
Stock Turnover n/a

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Jul '14) vs. prior year
Sales Growth n/a %
EPS Growth n/a %
3yr Compound Annual Growth Rate
Sales Growth n/a %
EPS Growth n/a %
DPS Growth -15.7 %
Graphical History Current Fiscal Year 2015

Broker Forecasts
31st Jul 2015
31st Jul 2016

Price Target: N/A Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a () () () () () ()
Consensus Estimate - - - - - -
1m Change - - - - - -
3m Change - - - - - -
Broker Consensus Trend
Broker Recommendations for Manchester and London Investment Trust Closed Fund
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

Profile Summary

Manchester and London Investment Trust plc (MLIT) is a United Kingdom-based investment trust. The Trust’s objective is to achieve capital appreciation together with a reasonable level of income, through investing in understandable, cash generative, liquid equity investments. The Trust’s seekd to achieve its investment objective through a policy of actively investing in a diversified portfolio, consisting the United Kingdom and overseas equities and fixed interest securities. The Trust’s principal portfolio includes PZ Cussons plc, AstraZeneca plc , Diageo plc , Jardine Matheson Holdings Ltd, Glencore plc, Afren plc, BG Group plc, Shire plc ,Unilever plc and bioMerieux SA. The Trust’s investment manager is Midas Investment Management Ltd.

Directors: Peter Thomas (SEC) , Peter Stanley (NEC) 79, Brett Miller (NED) 45, David Harris (NID) 63,

No. of Employees: 0 No. of Shareholders: 0


Last Annual July 31st, 2014
Last Interim July 31st, 2014
Shares in Issue 21,541,774
Free Float 20.9m (97.1%)
Sector Financials
Industry Collective Investments
Index FTSE Fledgling ,
Exchange London Stock Exchange (Full) (Dual Listing)
Eligible for an ISA? a SIPP?

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy MNL

Access MNL Analytics Now!

FREE TRIAL or TAKE THE TOUR